Privi Speciality Chemicals: FY24 Revenue of Rs 1,779 Crore

Privi Speciality Chemicals Limited reported revenue of Rs 1,779 crore in FY24, underlining its position in India's aroma and fragrance chemicals industry. The company manufactures, supplies and exports bulk aroma chemicals used in fragrance formulations. Its business combines pine chemistry, backward integration and a portfolio spanning more than 70 products. Privi has also reported continued growth in subsequent quarterly disclosures. For Q1 FY26, standalone revenue from operations grew 29.6% year-on-year, while consolidated revenue from operations rose 21.7%. The company has not provided the corresponding absolute Q1 revenue figures in the material supplied. Its operations and product mix remain relevant for investors tracking India's speciality chemicals exporters.

A manufacturer focused on aroma chemicals

Aroma chemicals are speciality chemicals that form key ingredients in fragrance formulations. Privi identifies itself as India's leading manufacturer, supplier and exporter in this category. The company also states that it holds leadership positions globally in products such as dihydromyrcenol, Amber Fleur, terpineol and pine oil. Its customer base includes leading global fragrance and FMCG companies. According to its FY24 presentation, the company serves more than 15 of the world's largest fragrance and FMCG companies. It has a presence in more than 30 countries. Exports contributed more than 70% of its business, according to the same presentation. This makes overseas demand and global fragrance industry conditions important operating considerations.

FY24 revenue provides the financial benchmark

Privi reported FY24 revenue of Rs 1,779 crore. The company described its historical growth as profitable, although the supplied material does not provide FY24 EBITDA or net profit figures. Earlier disclosures show that revenue was Rs 283.51 crore in FY21, based on the figures stated in lakhs and converted to crore. The FY24 figure reflects a much larger reported revenue base than FY21. However, the supplied presentations do not provide a like-for-like explanation for every change across the period. Investors should therefore distinguish between reported revenue growth and conclusions about margins, volumes or prices that are not detailed in the available data.

Q2 FY25 crossed the Rs 500 crore mark

In its October 2024 investor presentation, Privi said it recorded its best-ever quarterly performance at that point. The company stated that quarterly revenue grew 16% year-on-year and crossed Rs 500 crore for the first time. It attributed the performance to steady demand, operational efficiencies and a better product mix. It also said that these factors had contributed to margins above 20% over the preceding six quarters. The presentation did not provide the exact quarterly revenue number beyond stating that it exceeded Rs 500 crore. It also did not provide an exact EBITDA margin in the supplied material. The statement nevertheless indicates an improvement in the scale of quarterly operations during FY25.

Product mix remains centred on pine chemistry

Privi's product portfolio is organised across pinene, phenol, citral and speciality segments. Pinene accounts for about 70% of sales, according to the company's presentation. This concentration makes the segment central to its revenue profile. The company produces products including dihydromyrcenol, Amber Fleur, pine oil, terpineol, citronellal and cyclocitral. In the October 2024 presentation, Privi said DHMOL, AmberFleur and Galaxmusk were operating at optimal capacity. It added that newer products Indomerane and Florovane had started contributing meaningfully. The disclosures point to both established high-volume products and new-product additions within the portfolio.

Manufacturing network and integration

The company has integrated manufacturing facilities at Mahad in Maharashtra and Jhagadia in Gujarat. Its FY24 presentation listed seven manufacturing facilities and total production capacity of more than 48,000 tonnes per annum. This is higher than the earlier disclosed capacity of more than 36,000 tonnes per annum. Privi's processes include hydrogenation, condensation, Grignard reactions, pyrolysis and several distillation operations. Unit 2 is described as the company's largest unit. It manufactures DHMOL, citral-based and speciality products, and houses crude sulphated turpentine and gum turpentine processing. The company describes this refinery as the world's single largest, though no capacity figure was provided in the supplied information.

Greenfield facility adds to operations

Privi stated in October 2024 that it had commenced operations at a greenfield facility in Mahad, Maharashtra. The company also referred to the commissioning of PRIGIV, a greenfield plant structured as a joint venture with Givaudan SA. The supplied disclosure does not specify the plant's capacity, investment, revenue contribution or commissioning date. It therefore remains unclear from the available material how much of the FY25 and FY26 operating performance can be attributed to the new facility. Still, the start of operations marks an expansion of the company's production platform. It also aligns with Privi's stated effort to expand its speciality aroma chemical offering.

Profit growth in the December 2024 quarter

In its February 2025 investor presentation covering the quarter and nine months ended December 31, 2024, Privi stated that revenue increased 16% year-on-year. EBITDA grew 29% year-on-year and profit after tax rose 90% year-on-year. The company did not provide absolute revenue, EBITDA or profit after tax figures in the supplied excerpt. As a result, the disclosure supports an assessment of growth rates rather than absolute quarterly profitability. The difference between revenue and EBITDA growth suggests that profitability improved faster than sales during the stated comparison period. But the exact margin movement cannot be calculated without the underlying figures. Investors will need the full financial statements for a detailed assessment of costs, finance expenses and tax effects.

Corporate history and listed status

The company was initially incorporated as Fairchem Speciality Limited on May 25, 1985, according to the company information provided. It changed its name to Privi Speciality Chemicals Limited on October 14, 2020. Some investor presentation material refers to incorporation in 1982, while the supplied corporate-history text specifies the 1985 incorporation date. Privi started manufacturing aroma chemicals in 1992 with two products. It subsequently expanded its range to more than 75 products in one company profile, while FY24 presentations refer to more than 70 products. The variation reflects different disclosure dates and portfolio descriptions. The company is independently listed, with BSE scrip code 530117 and NSE symbol PRIVISCL.

What the disclosures mean for investors

Privi's FY24 revenue of Rs 1,779 crore, export contribution above 70% and expanding manufacturing platform place it among Indian chemical companies with significant exposure to global end markets. Its strength in pine chemistry and integrated processing is central to the operating model described in its presentations. At the same time, the substantial share of sales from the pinene segment indicates product-segment concentration. The reported Q1 FY26 revenue growth and earlier FY25 profit growth provide evidence of continuing momentum, but the supplied information does not include all absolute quarterly financial data. The company has made its investor presentations available through its website and exchange disclosures. Future updates on utilisation, new-product contribution, exports and the Mahad greenfield facility will offer further evidence on operating progress.

Conclusion

Privi Speciality Chemicals reported FY24 revenue of Rs 1,779 crore and continued to disclose year-on-year revenue growth in FY25 and Q1 FY26. Its business is anchored in aroma chemicals, pine chemistry, exports and integrated manufacturing. The next investor presentations and financial disclosures will be important for assessing the contribution of newer products and recently commissioned facilities.